Harvard Bioscience, Inc. (HBI.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 04:17PM CEST
| Previous Close | 3.8000 |
| Open | 3.8000 |
| Bid | 0.0000 x 240000 |
| Ask | 0.0000 x 240000 |
| Day's Range | 3.8000 - 3.8800 |
| 52 Week Range | 1.9600 - 5.6500 |
| Volume | |
| Avg. Volume | 60 |
| Market Cap | 168.597M |
| Beta (5Y Monthly) | 1.62 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1100 |
| Earnings Date | Nov 06, 2023 - Nov 10, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.00 |
GlobeNewswireHarvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research
Includes dedicated version for integration with Ponemah data management software from Data Sciences International (DSI) Expands reach of unique, non-invasive wearable monitoring for pre-clinical research across North American and European markets HOLLISTON, Mass. and LYON, France, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) and Etisense announced today that they have entered into an agreement to offer DECRO®, Etisense’s non-invasive telemetry jacket and associated
Simply Wall St.Harvard Bioscience, Inc. (NASDAQ:HBIO) Shares Could Be 36% Below Their Intrinsic Value Estimate
Key Insights The projected fair value for Harvard Bioscience is US$6.54 based on 2 Stage Free Cash Flow to Equity...
- Simply Wall St.
Harvard Bioscience President Acquires 1.6% More Stock
Potential Harvard Bioscience, Inc. ( NASDAQ:HBIO ) shareholders may wish to note that the President, James Green...
© 2023 Yahoo. All rights reserved.
